ArticleBMC biology2026
Hypoxia-induced exosomal circ_0006840 promotes pancreatic cancer progress by regulating the WIF1 decay.
Article in BMC biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundCircular RNAs (circRNAs) have been recognized as key contributors to tumorigenesis in various cancer types. However, the biological functions and mechanisms of hypoxia-induced exosomal circRNAs in pancreatic cancer (PC) are largely unknown.
methodsA comparison of hypoxic versus normoxic PC cells was conducted using RNA sequencing to identify differentially expressed circRNAs. Quantitative reverse transcription PCR (RT-qPCR) and in situ hybridization (ISH) was used to assess the expression levels of circ_0006840 in PC patients. In vitro and in vivo experiments were conducted to validate the biological functions of circ_0006840 in PC. Gene expression regulation was observed by RNA pull-down, ChIP, RIP, dual-luciferase assays. Gain- and loss-of-function studies were performed to observe the impacts of circRNA and its partners on the invasion, and metastasis of PC cells.
resultsWe identified differentially expressed circRNAs in exosomes derived from normoxic and hypoxic PC cells through RNA sequencing. We show that high level of circ_0006840 was found in PC tissues and serum exosomes, which was associated with poor patient survival. Both in vitro and in vivo, circ_0006840 enhanced PC cell proliferation and migration. At the transcriptional level, HIF1A mediated circ_0006840 activation. WNT inhibitory factor 1 (WIF1), a key component of the WNT signaling pathway, was identified as the primary target of circ_0006840, suppressed at the post-transcriptional level. These findings suggest that circ_0006840, activated by HIF1A, regulated WIF1 transcripts promoting their decay. Exosomal circ_0006840 thus emerges as a potential therapeutic target for PC.
conclusionsIt has been shown that circ_0006840 was transcriptionally activated by HIF1A and specifically regulated WIF1 transcripts, which is considered a potential target for PC therapy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.